Clinical Trial Update: ZR-MTX for PIOL Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II trial evaluating ZR-MTX for primary intraocular lymphoma has not yet recruited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Lymphoma

Drugs mentioned

• ZR-MTX

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Primary Intraocular Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING